Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-Small Cell Lung Cancer Associated With Poor Prognosis

Epidermal growth factor receptor (EGFR)-mutation-positive non-small cell lung cancer (NSCLC) is incurable, despite high rates of response to EGFR tyrosine kinase inhibitors (TKIs). We investigated receptor tyrosine kinases (RTKs), Src family kinases and focal adhesion kinase (FAK) as genetic modifie...

Descripción completa

Detalles Bibliográficos
Autores principales: Karachaliou, Niki, Chaib, Imane, Cardona, Andres Felipe, Berenguer, Jordi, Bracht, Jillian Wilhelmina Paulina, Yang, Jie, Cai, Xueting, Wang, Zhigang, Hu, Chunping, Drozdowskyj, Ana, Servat, Carles Codony, Servat, Jordi Codony, Ito, Masaoki, Attili, Ilaria, Aldeguer, Erika, Capitan, Ana Gimenez, Rodriguez, July, Rojas, Leonardo, Viteri, Santiago, Molina-Vila, Miguel Angel, Ou, Sai-Hong Ignatius, Okada, Morihito, Mok, Tony S., Bivona, Trever G., Ono, Mayumi, Cui, Jean, Cajal, Santiago Ramón y, Frias, Alex, Cao, Peng, Rosell, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925453/
https://www.ncbi.nlm.nih.gov/pubmed/29433983
http://dx.doi.org/10.1016/j.ebiom.2018.02.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925453/
https://www.ncbi.nlm.nih.gov/pubmed/29433983
http://dx.doi.org/10.1016/j.ebiom.2018.02.001

Ejemplares similares